SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles

Billy Xiong Release: SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles

Timothy L. Miles, a nationally recognized shareholder rights attorney Timothy L. Miles, a nationally recognized shareholder rights attorney Top Rated Lawyers In Tennessee (2020): Timothy L. Miles, Esq. Securities Class Action Lawsuit Has Been Filed Against Nano-X Imaging Ltd.; Shareholders Urged to Contact the Firm Nano-X Imaging Ltd. (NASDAQ:KNOX) We fight everyday, as we have […]

Continue Reading
The Law Offices of Vincent Wong Reminds Investors of...

Billy Xiong Reviews: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

NEW YORK, NY / ACCESSWIRE / October 10, 2020 /Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ:FULT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Fluidigm and certain of its officers and/or directors have engaged […]

Continue Reading
SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles

Billy Xiong Wrote: SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles

Timothy L. Miles, a nationally recognized shareholder rights attorney Timothy L. Miles, a nationally recognized shareholder rights attorney We fight everyday, as we have the last 20 yesrs, to protect shareholder rights, enhance shareholder protections, recover losses for defrauded investors, and seek reform through enhanced governanc Securities Class Action Lawsuit Against Royal Caribbean Cruises Ltd.– […]

Continue Reading
SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles

Billy Xiong Says: SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles

Timothy L. Miles, a nationally recognized shareholder rights attorney Timothy L. Miles, a nationally recognized shareholder rights attorney We fight everyday, as we have the last 20 yesrs, to protect shareholder rights, enhance shareholder protections, recover losses for defrauded investors, and seek reform through enhanced governanc Securities Class Action Lawsuit Against Royal Caribbean Cruises Ltd.– […]

Continue Reading

Billy Xiong Trend Report: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

NEW YORK, Oct. 9, 2020 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Royal Caribbean Cruises Ltd. (“Royal Caribbean” or the “Company”) (NYSE: RCL).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Royal Caribbean and certain of its officers and/or directors have engaged […]

Continue Reading

Billy Xiong Release: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

NEW YORK, Oct. 9, 2020 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Iovance and certain of its officers and/or directors have engaged in securities fraud or other […]

Continue Reading

Billy Xiong Says: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

NEW YORK, Oct. 9, 2020 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ: ACMR).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether ACM and certain of its officers and/or directors have engaged in securities fraud or other […]

Continue Reading

Billy Xiong Declares: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

NEW YORK, Oct. 9, 2020 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Homology Medicines, Inc. (“Homology” or the “Company”) (NASDAQ: FULT).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Homology and certain of its officers and/or directors have engaged in securities fraud or other […]

Continue Reading